cobalt health
cobalt health Company Information
Group Structure
View All
Industry
Specialist medical practice activities
+1Registered Address
linton house clinic, thirlestaine road, cheltenham, gloucestershire, GL53 7AS
Website
www.cobalthealth.co.ukcobalt health Estimated Valuation
Pomanda estimates the enterprise value of COBALT HEALTH at £20.9m based on a Turnover of £25.4m and 0.82x industry multiple (adjusted for size and gross margin).
cobalt health Estimated Valuation
Pomanda estimates the enterprise value of COBALT HEALTH at £5.9m based on an EBITDA of £980.1k and a 5.99x industry multiple (adjusted for size and gross margin).
cobalt health Estimated Valuation
Pomanda estimates the enterprise value of COBALT HEALTH at £73.1m based on Net Assets of £31.9m and 2.3x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Cobalt Health Overview
Cobalt Health is a live company located in cheltenham, GL53 7AS with a Companies House number of 04366596. It operates in the specialists medical practice activities sector, SIC Code 86220. Founded in February 2002, it's largest shareholder is unknown. Cobalt Health is a mature, large sized company, Pomanda has estimated its turnover at £25.4m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Cobalt Health Health Check
Pomanda's financial health check has awarded Cobalt Health a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 4 areas for improvement. Company Health Check FAQs
6 Strong
1 Regular
4 Weak
Size
annual sales of £25.4m, make it larger than the average company (£604.9k)
£25.4m - Cobalt Health
£604.9k - Industry AVG
Growth
3 year (CAGR) sales growth of 5%, show it is growing at a slower rate (7.6%)
5% - Cobalt Health
7.6% - Industry AVG
Production
with a gross margin of 46.2%, this company has a comparable cost of product (46.2%)
46.2% - Cobalt Health
46.2% - Industry AVG
Profitability
an operating margin of -6.8% make it less profitable than the average company (10%)
-6.8% - Cobalt Health
10% - Industry AVG
Employees
with 174 employees, this is above the industry average (15)
174 - Cobalt Health
15 - Industry AVG
Pay Structure
on an average salary of £45.9k, the company has a higher pay structure (£28.4k)
£45.9k - Cobalt Health
£28.4k - Industry AVG
Efficiency
resulting in sales per employee of £145.8k, this is more efficient (£58.5k)
£145.8k - Cobalt Health
£58.5k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Cobalt Health
- - Industry AVG
Creditor Days
its suppliers are paid after 57 days, this is slower than average (27 days)
57 days - Cobalt Health
27 days - Industry AVG
Stock Days
it holds stock equivalent to 1 days, this is less than average (12 days)
1 days - Cobalt Health
12 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 45 weeks, this is less cash available to meet short term requirements (101 weeks)
45 weeks - Cobalt Health
101 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 10.1%, this is a lower level of debt than the average (25.9%)
10.1% - Cobalt Health
25.9% - Industry AVG
COBALT HEALTH financials
Cobalt Health's latest turnover from March 2024 is £25.4 million and the company has net assets of £31.9 million. According to their latest financial statements, Cobalt Health has 174 employees and maintains cash reserves of £3.1 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 25,362,330 | 26,842,874 | 22,884,178 | 21,674,569 | 13,749,937 | 11,785,638 | 10,604,714 | 9,839,733 | 8,770,198 | 8,200,792 | 7,892,752 | 6,423,514 | 6,061,862 | 5,220,385 | 6,480,878 |
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | |||||||||||||||
| Gross Profit | |||||||||||||||
| Admin Expenses | |||||||||||||||
| Operating Profit | |||||||||||||||
| Interest Payable | |||||||||||||||
| Interest Receivable | |||||||||||||||
| Pre-Tax Profit | -1,562,630 | 913,794 | 2,931,761 | 6,802,534 | 934,772 | 891,731 | 999,785 | 1,211,867 | 926,228 | 960,932 | 1,036,403 | -21,274 | 310,414 | 13,061 | 1,471,318 |
| Tax | |||||||||||||||
| Profit After Tax | -1,562,630 | 913,794 | 2,931,761 | 6,802,534 | 934,772 | 891,731 | 999,785 | 1,211,867 | 926,228 | 960,932 | 1,036,403 | -21,274 | 310,414 | 13,061 | 1,471,318 |
| Dividends Paid | |||||||||||||||
| Retained Profit | -1,562,630 | 913,794 | 2,931,761 | 6,802,534 | 934,772 | 891,731 | 999,785 | 1,211,867 | 926,228 | 960,932 | 1,036,403 | -21,274 | 310,414 | 13,061 | 1,471,318 |
| Employee Costs | 7,988,845 | 6,933,009 | 5,264,089 | 4,354,826 | 3,869,731 | 3,445,624 | 3,165,208 | 3,016,949 | 2,729,730 | 2,592,094 | 2,242,885 | 1,916,479 | 1,735,736 | ||
| Number Of Employees | 174 | 161 | 131 | 117 | 102 | 95 | 91 | 84 | 73 | 68 | 60 | 47 | 43 | 45 | 42 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 24,165,483 | 25,293,206 | 22,730,795 | 19,763,130 | 17,039,593 | 14,611,320 | 14,570,197 | 14,616,910 | 12,480,943 | 13,502,109 | 11,724,865 | 12,544,630 | 12,332,327 | 12,090,576 | 11,533,344 |
| Intangible Assets | 77,276 | 104,082 | 169,577 | 189,491 | 144,003 | 67,061 | 146,921 | 153,215 | 172,915 | ||||||
| Investments & Other | 150,001 | 150,001 | 150,001 | 150,001 | 150,001 | 1 | 1 | 1 | 1,250,001 | 1 | |||||
| Debtors (Due After 1 year) | |||||||||||||||
| Total Fixed Assets | 24,392,760 | 25,547,289 | 23,050,373 | 20,102,622 | 17,333,597 | 14,678,382 | 14,717,119 | 14,770,126 | 13,903,859 | 13,502,110 | 11,724,865 | 12,544,630 | 12,332,327 | 12,090,576 | 11,533,344 |
| Stock & work in progress | 60,047 | ||||||||||||||
| Trade Debtors | 131,117 | 332,333 | 139,745 | 1,098,653 | 20,722 | 18,788 | 2,143 | ||||||||
| Group Debtors | 360 | 290 | |||||||||||||
| Misc Debtors | 4,717,094 | 4,417,477 | 3,984,521 | 3,790,125 | 2,466,978 | 2,231,737 | 1,762,461 | 1,511,996 | 1,691,261 | 166,954 | 897,657 | 815,441 | 650,987 | 490,051 | 701,019 |
| Cash | 3,089,764 | 4,729,476 | 5,929,071 | 6,146,392 | 3,608,590 | 1,166,001 | 725,621 | 2,945,443 | 3,688,451 | 3,592,515 | 4,711,137 | 2,859,888 | 3,227,769 | 3,208,237 | 3,835,617 |
| misc current assets | 3,204,561 | 3,095,910 | 3,045,102 | 3,032,265 | 2,050,833 | 4,534,405 | 4,002,177 | 1,250,000 | |||||||
| total current assets | 11,071,466 | 12,242,863 | 12,958,694 | 12,968,782 | 8,126,401 | 8,063,260 | 6,822,592 | 5,847,184 | 5,379,712 | 4,858,122 | 5,629,516 | 3,694,117 | 3,880,899 | 3,698,648 | 4,536,926 |
| total assets | 35,464,226 | 37,790,152 | 36,009,067 | 33,071,404 | 25,459,998 | 22,741,642 | 21,539,711 | 20,617,310 | 19,283,571 | 18,360,232 | 17,354,381 | 16,238,747 | 16,213,226 | 15,789,224 | 16,070,270 |
| Bank overdraft | |||||||||||||||
| Bank loan | 613,183 | 80,163 | 44,751 | ||||||||||||
| Trade Creditors | 2,144,814 | 2,309,164 | 1,198,722 | 1,345,550 | 1,988,067 | 517,557 | 261,781 | 331,283 | 238,422 | 259,697 | 308,257 | 196,242 | 199,217 | 185,515 | 118,228 |
| Group/Directors Accounts | |||||||||||||||
| other short term finances | |||||||||||||||
| hp & lease commitments | 150,727 | 145,023 | 139,534 | 134,253 | |||||||||||
| other current liabilities | 1,247,084 | 1,087,824 | 1,128,809 | 810,315 | 688,008 | 374,934 | 320,510 | 328,392 | 299,381 | 280,995 | 187,516 | 220,300 | 170,530 | 198,144 | 559,538 |
| total current liabilities | 3,542,625 | 4,155,194 | 2,547,228 | 2,334,869 | 2,676,075 | 892,491 | 582,291 | 659,675 | 537,803 | 540,692 | 495,773 | 416,542 | 369,747 | 383,659 | 677,766 |
| loans | 595,653 | 662,576 | |||||||||||||
| hp & lease commitments | 52,219 | 202,946 | 347,968 | 487,502 | |||||||||||
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | |||||||||||||||
| provisions | |||||||||||||||
| total long term liabilities | 52,219 | 202,946 | 943,621 | 1,150,078 | |||||||||||
| total liabilities | 3,594,844 | 4,358,140 | 3,490,849 | 3,484,947 | 2,676,075 | 892,491 | 582,291 | 659,675 | 537,803 | 540,692 | 495,773 | 416,542 | 369,747 | 383,659 | 677,766 |
| net assets | 31,869,382 | 33,432,012 | 32,518,218 | 29,586,457 | 22,783,923 | 21,849,151 | 20,957,420 | 19,957,635 | 18,745,768 | 17,819,540 | 16,858,608 | 15,822,205 | 15,843,479 | 15,405,565 | 15,392,504 |
| total shareholders funds | 31,869,382 | 33,432,012 | 32,518,218 | 29,586,457 | 22,783,923 | 21,849,151 | 20,957,420 | 19,957,635 | 18,745,768 | 17,819,540 | 16,858,608 | 15,822,205 | 15,843,479 | 15,405,565 | 15,392,504 |
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | |||||||||||||||
| Depreciation | 2,647,977 | 2,388,570 | 1,974,083 | 1,684,561 | 1,261,423 | 1,388,452 | 1,537,944 | 1,152,158 | 1,115,932 | 1,030,904 | 1,426,637 | 1,284,346 | 1,215,184 | 1,024,067 | 840,398 |
| Amortisation | 65,495 | 65,495 | 67,149 | 47,012 | 45,305 | 61,769 | 55,196 | 44,959 | |||||||
| Tax | |||||||||||||||
| Stock | 60,047 | ||||||||||||||
| Debtors | 299,617 | 432,956 | 194,396 | 1,323,147 | 104,124 | 268,060 | 443,053 | -39,520 | 425,654 | 347,228 | 84,150 | 181,099 | 162,719 | -210,898 | 701,309 |
| Creditors | -164,350 | 1,110,442 | -146,828 | -642,517 | 1,470,510 | 255,776 | -69,502 | 92,861 | -21,275 | -48,560 | 112,015 | -2,975 | 13,702 | 67,287 | 118,228 |
| Accruals and Deferred Income | 159,260 | -40,985 | 318,494 | 122,307 | 313,074 | 54,424 | -7,882 | 29,011 | 18,386 | 93,479 | -32,784 | 49,770 | -27,614 | -361,394 | 559,538 |
| Deferred Taxes & Provisions | |||||||||||||||
| Cash flow from operations | |||||||||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | -1,429,575 | -1,446,946 | -3,313,384 | -267,681 | -2,762,148 | -606,872 | -1,496,833 | -1,329,435 | -1,581,299 | -1,771,809 | |||||
| Change in Investments | 150,000 | -1,250,000 | 1,250,000 | 1 | |||||||||||
| cash flow from investments | -150,000 | -1,429,575 | -1,446,946 | -2,063,384 | -1,517,681 | -2,762,149 | -606,872 | -1,496,833 | -1,329,435 | -1,581,299 | -1,771,809 | ||||
| Financing Activities | |||||||||||||||
| Bank loans | -613,183 | 533,020 | 35,412 | 44,751 | |||||||||||
| Group/Directors Accounts | |||||||||||||||
| Other Short Term Loans | |||||||||||||||
| Long term loans | -595,653 | -66,923 | 662,576 | ||||||||||||
| Hire Purchase and Lease Commitments | -145,023 | -139,533 | -134,253 | 621,755 | |||||||||||
| other long term liabilities | |||||||||||||||
| share issue | |||||||||||||||
| interest | |||||||||||||||
| cash flow from financing | -758,206 | -202,166 | -165,764 | 1,329,082 | 127,500 | 13,921,186 | |||||||||
| cash and cash equivalents | |||||||||||||||
| cash | -1,639,712 | -1,199,595 | -217,321 | 2,537,802 | 2,442,589 | 440,380 | -2,219,822 | -743,008 | 95,936 | -1,118,622 | 1,851,249 | -367,881 | 19,532 | -627,380 | 3,835,617 |
| overdraft | |||||||||||||||
| change in cash | -1,639,712 | -1,199,595 | -217,321 | 2,537,802 | 2,442,589 | 440,380 | -2,219,822 | -743,008 | 95,936 | -1,118,622 | 1,851,249 | -367,881 | 19,532 | -627,380 | 3,835,617 |
cobalt health Credit Report and Business Information
Cobalt Health Competitor Analysis
Perform a competitor analysis for cobalt health by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other large companies, companies in GL53 area or any other competitors across 12 key performance metrics.
cobalt health Ownership
COBALT HEALTH group structure
Cobalt Health has 1 subsidiary company.
cobalt health directors
Cobalt Health currently has 10 directors. The longest serving directors include Dr Mark Callaway (Dec 2015) and Dr Janet Ropner (May 2019).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Dr Mark Callaway | England | 29 years | Dec 2015 | - | Director |
| Dr Janet Ropner | 78 years | May 2019 | - | Director | |
| Dr Valerie Udale | 63 years | Feb 2020 | - | Director | |
| Mrs Ruth Goddard | 60 years | Feb 2020 | - | Director | |
| Miss Claire Morris | 57 years | Jun 2022 | - | Director | |
| Mrs Pamela Sissons | England | 62 years | Jun 2022 | - | Director |
| Dr Felicity Jenkins | 69 years | Nov 2023 | - | Director | |
| Mr Matthew Jones | 55 years | Nov 2023 | - | Director | |
| Mr Philip Leonard | 58 years | Nov 2023 | - | Director | |
| Prof Gordon Wilcock | England | 79 years | Jan 2024 | - | Director |
P&L
March 2024turnover
25.4m
-6%
operating profit
-1.7m
0%
gross margin
46.2%
+0.02%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
31.9m
-0.05%
total assets
35.5m
-0.06%
cash
3.1m
-0.35%
net assets
Total assets minus all liabilities
cobalt health company details
company number
04366596
Type
Private Limited by guarantee without Share Capital Exempt from using Limited
industry
86220 - Specialist medical practice activities
86900 - Other human health activities
incorporation date
February 2002
age
23
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
March 2024
previous names
cobalt unit appeal fund (January 2015)
accountant
-
auditor
CROWE UK LLP
address
linton house clinic, thirlestaine road, cheltenham, gloucestershire, GL53 7AS
Bank
NATIONAL WESTMINSTER BANK PLC
Legal Advisor
WILLANS LLP
cobalt health Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to cobalt health. Currently there are 1 open charges and 0 have been satisfied in the past.
cobalt health Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for COBALT HEALTH. This can take several minutes, an email will notify you when this has completed.
cobalt health Companies House Filings - See Documents
| date | description | view/download |
|---|
